Supplemental materials

Clinical laboratory indices and ANAs
Routine laboratory data were gathered from hospital laboratory analyses; ANAs were assessed by indirect immunofluorescence staining of Hep-2 slides (Inova diagnostics, San Diego, USA) visualized with FITC Mouse Anti-Human IgG (Biosciences, Oxford, UK).
Histology and Immunohistochemistry
Liver biopsy specimens were stored in 10% formaldehyde-saline solution until embedded in paraffin and then cut into 4µM sections. Sections were subsequently dewaxed using Clearene® (Leica Biosystems, Newcastle Upon Tyne, UK), rehydrated using graded alcohols and water and then either stained with haematoxylin and eosin or Van Gieson stain using standard techniques or for specific antigens as below.
EBV-staining and in situ hybridization was performed using peptide nucleic acid kit K5201 and EBV virus probe Y5200 (both Dako UK Ltd, Cambridgeshire, UK) according to the manufacturer's instructions.
For FoxP3 staining, tissues non-specific staining was blocked with methanolhydrogen peroxide solution; antigen retrieval was performed by emersion in a high pH EDTA solution (Vector Laboratories Ltd, Peterborough, UK) and heating with a microwave; further non-specific staining was reduced by incubation with Casein solution (Vector); FoxP3 was stained with rat antihuman FoxP3 Biotin antibody (Clone PCH101, eBioscience, San Diego, CA, USA). B cells were stained with mouse anti-human CD20 antibody (Clone L26, Dako). Staining was visualised with anti-mouse or anti-rat peroxidase and 3, 3'-diaminobenzidine substrate (Vector). Sections were counter-stained with Mayer's haematoxylin.
Flow cytometry
Peripheral blood mononuclear cells were isolated from whole, EDTAanticoagulated blood by density gradient centrifugation using Lympholyte®-H (Cedarlane, Burlington, Canada). They were stored until analysed in media supplemented with fetal calf serum and 10% DMSO in liquid nitrogen until analysis.
Control blood was obtained from an otherwise healthy patient with genetic haemochromatosis undergoing routine therapeutic venesection. 
Sequencing of GATA-2
Peripheral blood was used as the source of DNA. Genomic DNA was extracted using the QIAamp DNA Mini Kit (QIAGEN), while polymerase chain reaction (PCR) amplification and Sanger sequencing was performed using primers and conditions described previously. 
Autoantibody tested Method Result
Anti-nuclear antibody 192-194/196/197/199-201/203-208/210-216 
